Novo Nordisk, a pharmaceutical company founded in Denmark in 1923, has been a pioneer of innovative insulin delivery methods for the treatment of diabetes with brand names Levomir® (an injection pen that uses a pre-filled, replaceable insulin cartridge) and AERx® (an insulin inhalant). While Novo Nordisk continues to be the world leader in diabetes treatment, the company has expanded into other areas of research and development including human growth hormone and hemostatic products in their biopharmaceuticals. …
